Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.002 AUD
−1.35 M AUD
6.49 M AUD
220.01 M
About PHARMX TECHNOLOGIES LIMITED
Sector
Industry
CEO
Tom Culver
Website
Headquarters
Sydney
Founded
1950
ISIN
AU0000298762
FIGI
BBG000BQ8554
PharmX Technologies Ltd. engages in the research and development of software solutions. It operates through the Health Services and eCommerce segment. The Health Services segment provides dispense and point of sale software applications, along with hardware and support services to Australian pharmacies. The eCommerce segment offers individuals and businesses the opportunity to pay their rent, utilities, local government fees, and commercial obligations via electronic methodologies. The company was founded in 1950 and is headquartered in Sydney, Australia.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of PHX is 0.068 AUD — it has decreased by −2.86% in the past 24 hours. Watch PHARMX TECHNOLOGIES LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange PHARMX TECHNOLOGIES LIMITED stocks are traded under the ticker PHX.
PHX stock has fallen by −5.56% compared to the previous week, the month change is a 19.30% rise, over the last year PHARMX TECHNOLOGIES LIMITED has showed a 78.95% increase.
PHX stock is 4.41% volatile and has beta coefficient of 3.21. Track PHARMX TECHNOLOGIES LIMITED stock price on the chart and check out the list of the most volatile stocks — is PHARMX TECHNOLOGIES LIMITED there?
Today PHARMX TECHNOLOGIES LIMITED has the market capitalization of 40.70 M, it has increased by 2.90% over the last week.
Yes, you can track PHARMX TECHNOLOGIES LIMITED financials in yearly and quarterly reports right on TradingView.
PHARMX TECHNOLOGIES LIMITED is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
PHX net income for the last half-year is −99.00 K AUD, while the previous report showed −1.25 M AUD of net income which accounts for 92.09% change. Track more PHARMX TECHNOLOGIES LIMITED financial stats to get the full picture.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMX TECHNOLOGIES LIMITED EBITDA is 1.52 M AUD, and current EBITDA margin is 23.46%. See more stats in PHARMX TECHNOLOGIES LIMITED financial statements.
Like other stocks, PHX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMX TECHNOLOGIES LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMX TECHNOLOGIES LIMITED technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMX TECHNOLOGIES LIMITED stock shows the buy signal. See more of PHARMX TECHNOLOGIES LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.